With regard to the use of medication, based on recent literature, insulin, sulfonylurea, and thiazolidinediones use was associated with increased fracture risk in T2DM, while metformin use was associated with a decreased fracture risk. The gene discussed is INS; the disease is type 2 diabetes mellitus.